Fulgent Genetics, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on May 14, 2026, specifically the 2026 Annual Meeting of Stockholders held at the company's principal executive offices in El Monte, California. The filing details the election of directors, ratification of auditors, advisory vote on executive compensation, and the approval of a new equity incentive plan.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. No financial statements are included in this document.
Material Changes and Corporate Actions
- Equity Incentive Plan Approval: Stockholders approved the 2026 Equity Incentive Plan, replacing the 2016 Omnibus Incentive Plan. The new plan authorizes the issuance of 2,000,000 new shares of common stock, plus up to 1,500,000 additional shares from forfeited or cancelled awards under the prior plan.
- Director Elections: Four directors were elected to serve until the 2027 Annual Meeting: Ming Hsieh, Linda Dong, Michael Nohaile, Ph.D., and Regina Groves.
- Auditor Ratification: Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Executive Compensation: Stockholders approved, on a non-binding advisory basis, the compensation of the named executive officers.
Voting Results and Shareholder Engagement
As of the record date (March 20, 2026), there were 29,747,420 shares eligible to vote. A quorum of 24,578,996 shares (approximately 83%) was present. Key voting outcomes included:
- Proposal 1 (Directors): Ming Hsieh received the highest support (21,979,668 votes for), while Linda Dong received the most votes withheld (5,419,162).
- Proposal 2 (Auditor): Overwhelmingly approved with 24,470,414 votes for and only 87,192 votes against.
- Proposal 3 (Say-on-Pay): Approved with 19,800,226 votes for, though 2,410,239 votes were cast against.
- Proposal 4 (Equity Plan): Approved with 18,693,758 votes for, with 3,513,983 votes against.
Investor Verification Checklist
- Verify the total number of shares authorized under the new 2026 Equity Incentive Plan (2,000,000 new + 1,500,000 rollover) and its potential dilution impact.
- Review the full text of the 2026 Equity Incentive Plan (Exhibit 10.1) for specific vesting schedules and eligibility criteria.
- Monitor the level of dissent in the Say-on-Pay vote (approx. 10.8% against) and the significant votes withheld for director Linda Dong (approx. 22% of votes cast).
- Confirm the transition timeline for equity awards from the 2016 Plan to the 2026 Plan to ensure no disruption in employee compensation.